The 2024 CDD European Life Science Community Meeting was a resounding success, bringing together leaders, researchers, and innovators from across the continent to discuss the latest advancements in life sciences and drug discovery. Held at the University Arms Hotel in Cambridge, United Kingdom, on September 25, 2024, the event provided a platform for knowledge sharing and collaboration, with a focus on how innovative technologies like data management, AI, and advanced research tools are driving progress in drug discovery. Registration for the Community Meeting was open on Day 1, with an optional training session offered on Day 2, September 26, 2024.
Event Highlights
Key presentations explored the ways cutting-edge technologies are transforming research workflows, accelerating discoveries, and fostering collaboration across the scientific community. The event underscored the growing importance of data-driven approaches and AI in the future of drug discovery.
A special thank you to all our speakers for sharing their expertise and contributing to the event’s success.
Key sessions and discussions at the meeting included:
- Data Management Solutions in Drug Discovery: Presenters emphasized the critical role of robust data management systems like CDD Vault, which streamline research processes and foster greater collaboration across scientific teams.
- FAIR Principles in Life Sciences: Speakers highlighted the impact of adhering to FAIR (Findable, Accessible, Interoperable, and Reusable) data principles, showing how they are revolutionizing data handling practices and improving research outcomes.
- Emerging Trends in AI and Machine Learning: Groundbreaking insights were shared on the applications of AI and machine learning in accelerating drug discovery processes, offering new ways to harness data for scientific advancements.
- Simplifying Assay Data Management: A key session demonstrated how CDD Vault simplifies assay data management, helping scientists navigate complex data while adhering to FAIR standards.
- Fostering Collaboration in Science: Engaging discussions explored the vital role of collaboration in drug discovery, with an emphasis on how data-sharing platforms enable researchers to work together more effectively, unlocking new possibilities for innovation.
Keynote Speakers:
- Atf Nagbou. Director BD, Axxam
- Dr Benedict Cross, CTO, Phoremost
- Dr Ben Allen, Principal Scientist, MoA Technologies.
- Dr David Foley, Associate Director of Chemistry, Tay Therapeutics
- Dr Ed Griffen, COVID Moonshot and Technical Director of Medchemica
- Dr Etienne Donckele - Associate Director of Chemistry, Monte Rosa Therapeutics
- Dr Gordon Saxty, NS-MC Consulting
- Dr James Dale, Director of Chemistry, PharmEnable Therapeutics
- Dr Jia Lu, Principal Scientist, Phoremost
- Dr Mat Calder, Principal Medicinal Chemist, Phoremost
- Dr Matthew Segall, Optibrium
- Dr Rebecca Clayton, RxCelerate
- Dr Simon Dawson, Principal Product Manager, Torx Software
- Dr Nathan Zaccai, Associated Principal Scientist, Domainex
- Dr Yuliia Holota, Sr. Manager Preclinical Pharmacology, Enamine Ltd.
- Kellan Gregory, Director of Product, CDD
- Charlie Weatherall, Director of Customer Engagement, CDD
- Dr Susana Tomasio, Sr Application Scientist, CDD
- Dr Antima Gupta, Application Scientist, CDD
- Emilia Hietala, Application Scientist, CDD
We Want to Hear From You:
Your insights are crucial as we continue to grow and evolve. A big thank you to everyone who participated and helped make this year’s Korean Life Science Community Meeting a success.
If you'd like to dive deeper into any of the topics discussed or have questions about future events, don't hesitate to reach out. Contact us at info@collaborativedrug.com to schedule a discussion or learn more about upcoming opportunities in 2024 and 2025.